COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1183: Articles 11821-11830  | Next

Scrutiny of human lung infection by SARS-CoV-2 and associated human immune responses in humanized mice
Hu, Z., Sun, R., Zhao, Z., Fu, C., Wang, Y., Guo, Z., Zhang, C., Liu, L., Zhang, C., Shu, C., He, J., Li, W., Zhou, Q., Gao, Y., Hua, S., Yang, Y.-G.
10.1101/2021.11.05.466755 — Posted: 2021-11-05
Evaluation of patients treated by telemedicine in the COVID-19 pandemic by a private clinic in Sao Paulo, Brazil: A non-randomized clinical trial preliminary study
Chechter, M., da Silva, G. M. D., Miklos, T. G., Kemp, M. M., da Silva, N. A., Lober, G. L., Zanut, M. F. T., e Costa, R. A. P., Cortada, A. P. d. S., da Cruz, L. d. N. L., de Melo, P. M. P., de Souza, B. C., Scheinberg, M. A.
10.1101/2021.11.05.21265569 — Posted: 2021-11-05
Optimising the quarantining and response sequence towards SARS-CoV-2 outbreaks on board cargo vessels
Ng, K. Y., Codreanu, T. A., Gui, M. M., Biglarbeigi, P., Finlay, D., McLaughlin, J.
10.1101/2021.11.03.21265201 — Posted: 2021-11-05
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
Zarn, K. E., Jaramillo, S. A., Zapata, A. R., Stone, N. E., Jones, A. N., Nunnally, H. E., Settles, E. W., Ng, K., Keim, P. S., Knudsen, S., Nuijten, P. M., Tijsma, A. S., French, C. T.
10.1101/2021.11.03.467186 — Posted: 2021-11-05
Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit
Urata, S., Kishimoto-Urata, M., Kagoya, R., Imamura, F., Nagayama, S., Reyna, R. A., Maruyama, J., Yamasoba, T., Kondo, K., Hasegawa-Ishii, S., Paessler, S.
10.1101/2021.11.04.467274 — Posted: 2021-11-05
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
Abdelnabi, R., Foo, C. S.-Y., Jochmans, D., Vangeel, L., De Jonghe, S., Augustijns, P., Mols, R., Weynand, B., Wattanakul, T., Hoglund, R., Tarning, J., Mowbray, C., Sjo, P., Escudie, F., Scandale, I., Chatelain, E., Neyts, J.
10.1101/2021.11.04.467077 — Posted: 2021-11-05
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques
Yu, J., Yao, W., Hu, Y., Wu, S., Li, J., Zhou, H., Hong, K., Chen, J., Liu, L., Lan, K., Zhu, F.-C., Liu, Y.
10.1101/2021.11.03.467182 — Posted: 2021-11-05
Machine Learning in the analysis of lethality and evolution of infection by the SARS-CoV-2 virus (COVID-19) in workers of the Mexico City Metro
Garcia Islas, E. I., De Anda Jauregui, G., Salas Rodriguez, J., Serrania Soto, F.
10.1101/2021.10.27.21265573 — Posted: 2021-11-05
Longitudinal Changes of Cardiac and Aortic Imaging Phenotypes Following COVID-19 in the UK Biobank Cohort
Bai, W., Raman, B., Peterson, S. E., Neubauer, S., Raisi-Estabragh, Z., Aung, N., Harvey, N. C., Allen, N., Collins, R., Matthews, P. M.
10.1101/2021.11.04.21265918 — Posted: 2021-11-05
Evaluation of a Machine Learning Approach Utilizing Wearable Data for Prediction of SARS-CoV-2 Infection in Healthcare Workers
Hirten, R. P., Tomalin, L., Danieletto, M., Golden, E., Zweig, M., Kaur, S., Helmus, D., Biello, A., Pyzik, R., Bottinger, E. P., Keefer, L., Charney, D., Nadkarni, G., Suarez-Farinas, M., Fayad, Z. A.
10.1101/2021.11.04.21265931 — Posted: 2021-11-05 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).